Asbestos news

 

60 seconds with mesothelioma and asbestos claims solicitor Annabelle Neilson

Annabelle qualified as a solicitor in September 2009 and joined Boyes Turner’s mesothelioma and asbestos claims team in December 2009. Annabelle represents claimants who have developed an asbestos-related disease such as mesothelioma, asbestos-related lung cancer, asbestosis and pleural thickening.

“Annabelle is held in great esteem by our family for all she has done for us throughout this traumatic time in our lives. Our thanks to her will never be enough.”

  • Who can bring an asbestos claim?

Anyone who has received a diagnosis of an asbestos-related disease such as mesothelioma, asbestos-related lung cancer, asbestosis or pleural thickening should look into making a claim for compensation. There is a long latency period from the time of exposure to asbestos dust to the time of diagnosis of an asbestos disease, which can be anywhere from 10-50 years.

  • Why should I instruct a specialist firm of solicitors?

Mesothelioma and asbestos-disease claims are complex and often require immediate, skilled attention, owing to the life-limiting nature of these conditions. As specialist mesothelioma and asbestos claims solicitors, Boyes Turner’s industrial disease team are highly experienced in dealing with these types of claim and the defendant representatives. We use our expertise to ensure that the claim is progressed swiftly and sensitively, sparing our clients and their families unnecessary delay in receiving their compensation.

  • Am I entitled to any benefits?

There are a number of benefits which you may be entitled to receive following a diagnosis of mesothelioma or another asbestos-related disease. These include Industrial Injuries Disablement Benefit, Pneumoconiosis etc (Workers’ Compensation) Act 1979 lump sum payments, Diffuse Mesothelioma Scheme 2008 lump sum payments, Diffuse Mesothelioma Scheme 2014 lump sum payments, attendance allowance, war veterans’ pension and constant attendance allowance. We can assist you in making applications for benefits which can help with the cost of treatment and any care which you may require.

  • How long will a claim take?

The length of each claim will vary and can largely depend upon the position taken by the defendants and whether or not they decide to defend the claim. We act quickly and proactively to minimise the duration of any compensation claim. We work with the asbestos masters and the asbestos and mesothelioma claims procedure in the High Court to ensure the swift progression of all our claims. We regularly achieve lifetime settlements, sometimes within six weeks from instruction, and we have secured interim payments of £50,000 within two weeks of receiving instructions to alleviate our clients’ financial hardship whilst the full value of the claim is investigated. Take a look at some of the mesothelioma and asbestos disease claims which we have settled on behalf of our clients.

  • How much will it cost?

We provide an initial consultation free of charge. At that meeting we advise our clients fully about their options, and then we discuss and agree together how best to fund the claim. We offer Conditional Fee Agreements (CFAs, also known as ‘no win, no fee’).

  • I have an asbestos-related disease. What should I do next?

Email Annabelle on idclaims@boyesturner.com and she will discuss with you the best course of action to achieve the best and quickest settlement of your claim.

Diffuse Mesothelioma Payment Scheme and veterans

The Diffuse Mesothelioma Payment Scheme (DMPS) was enacted in 2014 allowing mesothelioma victims to claim a lump sum payment from the Government where the negligent employer company or other organisation which caused the mesothelioma is no longer trading or its insurer cannot be traced; i.e. there is no defendant to pursue. Where armed forces veterans were exposed to asbestos before 1987 they are statute barred from pursuing a civil claim against the Ministry of Defence (MOD), leaving them also in a position of having no one to pursue.

Are veterans entitled to claim a payment from the DMPS?

The DMPS states that a mesothelioma victim is unable to claim a payment from the scheme where there is an entitlement to a payment from a MOD scheme such as the War Pensions Scheme (WPS).

So, what can veterans do?

On 16 December 2015 the MOD changed the rules of the WPS to allow mesothelioma victims to have the choice of receiving their WPS in regular, small payments (as in the original scheme) or as a one-off tax-free lump sum. The one-off tax-free lump sum was introduced to redress the imbalance between the WPS and the DMPS/civil compensation. The WPS was previously only paid as regular, small payments which ceased on the death of the mesothelioma victim. This meant that war veterans would often receive a fraction of what their civil counterparts would receive through the DMPS or a claim for compensation.

Does this mean that veterans will receive the same award as a civilian making a compensation claim?

In short, no. The WPS will pay £140,000 as a lump sum to mesothelioma victims making a claim. This means that in most cases the WPS payment is likely to under compensate mesothelioma victims. The amount is just below that paid for 75-year-olds under the DMPS.

What if someone has died from mesothelioma before a WPS claim has been made? Can their widows/dependents still claim?

In this situation a payment under the WPS will no longer be available. Instead, eligible widows and civil partners may apply for a War Widow’s Pension.

What if I have an asbestos-related disease other than mesothelioma?

The lump sum payment under the WPS is only available to those diagnosed with mesothelioma.

Who can help veterans make WPS applications?

Help is available for veterans from Mesothelioma UK who have a dedicated benefits advisor as a part of their armed forces service and work closely with Armed Forces UK. The Royal British Legion also provide help and support. Boyes Turner’s mesothelioma and asbestos claims team can help veterans with applications under the WPS.

If you or a family member are suffering from mesothelioma or other asbestos-related disease, email us at IDclaims@boyesturner.com for a free initial conversation. 

Mesothelioma asbestos and the Johnson & Johnson baby powder cases

Over the past couple of months Johnson & Johnson, a company synonymous with baby skin care products, with tag lines such as “clinically proven to be as mild as water”, have come under significant scrutiny following a $117m award of compensation for mesothelioma, after it was revealed through trial documentation that Johnson’s talc baby powder contained asbestos.

The decision to award damages in this case was made by a jury in New Brunswick, New Jersey. The claim was made against the company Johnson & Johnson Consumer Inc, together with Imerys Talc America Inc. According to reports, following consideration of confidential documentation from Johnsons’ company documents, the jury awarded the claimant $37m in compensation for his asbestos cancer mesothelioma. They also awarded $80m in punitive damages.  Punitive damages are awarded where compensation alone is seen to be inadequate and as a deterrent for any similar future practice by the company. 

The case in question was Steven and Kendra Lanzo v Johnson & Johnson Consumer Inc and Imerys Talc America Inc.  The claimants were represented by American mesothelioma law firm, Kazan Law, who advocate for the rights of asbestos victims. 

During the trial, confidential company documents were disclosed which revealed that the companies were aware that Johnson’s talc baby powder contained asbestos. Consequently, the jury found that Johnson & Johnson should stop selling Johnson’s talc baby powder and should replace the talc with cornstarch. 

The documents showed that Johnson & Johnson were aware since the 1960s that the talc used in its baby powder contained asbestos and that it could cause cancer. 

The talcum powder itself is not considered to be the cause of the mesothelioma, but the fact that it is contaminated with amphibole asbestos tremolite. Talcum powder and tremolite are substances created by the same geologic process, therefore, the materials are frequently found in the same areas.

The Johnson’s Baby UK website reassures its consumers that their baby powder does not contain asbestos. The website states, “Johnson’s® baby powder does not contain asbestos, a substance classified as cancer causing. The talc used in all our global production is carefully selected and processed to be asbestos free, which is confirmed by regular testing to confirm purity. Like all our products, Johnson’s baby powder contains only ingredients that have been fully evaluated by scientific and medical experts to ensure they are safe to use”. 

The link between mesothelioma and talcum powder remains controversial and Johnson & Johnson are expected to appeal the decision. The company has previously come under scrutiny for links between ovarian cancer and talcum powder, although large studies such as the Nurses’ Health Study (2010) and the Women’s Health Initiative Observational Cohort (2014) have found no causal link between talcum powder and ovarian cancer. However, these studies did not stop a jury in Missouri yesterday awarding $4.7 bn in damages to 22 women who alleged they had developed ovarian cancer after using their baby powder. Johnson & Johnson is set to appeal the decision.

Talcum powder is a controversial product and many midwives do not recommend the use of talcum powder, owing to the risk that it may be contributing to the growing number of children diagnosed with asthma. 

We will watch out for further developments in the asbestos talcum powder cases and await with interest the outcome of any appeal and any further documentation which Johnson & Johnson may produce.

Whether or not talcum powder poses an asbestos risk and a risk of mesothelioma appears from, the evidence, to be uncertain. What is clear is that talc can be contaminated with tremolite as a consequence of the natural process of its creation but the company maintains its position that the talc used in these products is asbestos free. 

What is certain is that the prolific use of asbestos in the past means that this is unlikely to be the last consumer product that we encounter which used to contain asbestos.

If you or a family member are suffering from mesothelioma or other asbestos-related disease, email us at IDclaims@boyesturner.com for a free initial conversation. 

Asbestos Court Users Meeting

On 13 June 2018, the High Court held an Asbestos Court Users Meeting. The meeting was chaired by Senior Master Fontaine with significant contributions from Master Davison, Master Eastman, Master McCloud, Master Thornett and Master Gidden.

Asbestos disease claims

When handling asbestos disease claims, we are fortunate to have dedicated Masters who oversee the swift progression of each and every case. Mesothelioma claims are prioritised and, using the dedicated asbestos list at the High Court, we are often able to progress them to trial within the lifetime of our mesothelioma clients.

Another way in which the High Court supports the needs of asbestos-related disease sufferers is by encouraging the parties’ legal representatives to make use of the ‘show cause’ procedure. By doing so, the court can identify swiftly those cases where liability is in dispute or where judgment on liability can be entered and the claim progressed quickly to an assessment of damages hearing.

The Masters

The Masters highlighted their expectation that by the first case management conference both the claimant and defendant must know where they stand in relation to a show cause hearing. If there is a simple, short point in dispute then this can be dealt with at the first 30 minute hearing. More complicated issues will require a longer hearing at a later date and the claimant and defendant are expected to provide for this in their directions.

The Masters clarified that all asbestos cases (not only mesothelioma claims) are appropriate for the show cause procedure, recognising the importance of the swift progression of any claim where an asbestos disease has been diagnosed. 

The Masters further demonstrated their commitment to the swift progress of these claims by confirming that, in the absence of compelling argument from any party for the need for cost budgeting, this is regarded as unnecessary in asbestos claims, given the potential for additional delay.

They emphasised the importance of the appointment of an expert mesothelioma and asbestos claims solicitor in these cases. Expert mesothelioma and asbestos claims solicitors understand the process and the procedure within the High Court for progressing asbestos disease claims. By instructing specialist experts and solicitors who follow these procedures, mesothelioma victims are more likely to be spared unnecessary delay in receiving their compensation. 

The Boyes Turner team

Boyes Turner’s industrial disease team are experts in asbestos-related disease cases and have an outstanding record of securing high value, lifetime, and provisional damages settlements, often succeeding where other less experienced lawyers have been unable to act.

If you or a family member are suffering from mesothelioma or other asbestos-related disease, contact is by email at IDclaims@boyesturner.com for a free initial conversation. 

Melloney Harbutt receives Asbestos Disease Specialist accreditation from APIL

Kim Smerdon, head of Boyes Turner’s successful industrial disease and personal injury teams is pleased to announce that senior associate solicitor, Melloney Harbutt, has been awarded Asbestos Disease Specialist status by APIL. 

Melloney acts exclusively for people from a wide range of trades and occupations who have suffered asbestos-related diseases, including pleural thickening, asbestosis and mesothelioma, with a particular interest and specialism in difficult lung cancer cases. She recovers compensation for individuals and their bereaved families from their former employers’ insurers, and for mesothelioma sufferers under the Diffuse Mesothelioma Payment Scheme. She achieves justice and compensation for those exposed indirectly to asbestos dust, such as on a relative’s clothes or from living close to an asbestos factory.

Melloney has dedicated her career to making a difference to the lives of those affected by asbestos. She works hard to secure lifetime settlements, provisional awards in case of possible future malignancy, and justice for her injured clients in hard fought and evidentially difficult cases, achieving success where less experienced solicitors might fail.

We are delighted that her expertise, commitment and dedication to helping these deserving clients has been recognised.

If you or a family member has been diagnosed with mesothelioma or any other asbestos related disease, we may be able to help. Contact us by email IDClaims@boyesturner.com for a free initial discussion.

Immunotherapy treatment for mesothelioma patients

Pembrolizumab – Immunotherapy treatment

Medical professionals are continually investigating new ways to help mesothelioma patients. There are always a number of different trials looking at improving symptoms and curing mesothelioma. All of these trials can be found by looking on the NHS website. One such treatment currently on offer is private immunotherapy treatment.

The treatment is with a drug called Pembrolizumab. Pembrolizumab has not yet been approved by the National Institute for Health Care and Excellence (“NICE”) in the treatment of mesothelioma patients and therefore currently is not available as a free treatment on the NHS. We are unaware of any indication that NICE will be approving Pembrolizumab any time soon.

Pembrolizumab has, however, in limited clinical trials, demonstrated increased survival rates in mesothelioma patients. It is therefore something that many patients with mesothelioma are considering.

How does immunotherapy treatment work?

Put simply, the drug works by making the cancer highly visible to the patient’s own immune system. The patient’s own immune system then kills the cancer.

Immunotherapy treatment and mesothelioma claims

As Pembrolizumab is not currently approved by NICE as a treatment for patients with mesothelioma and is therefore not available on the NHS, the current cost of treatment on a private basis is estimated at £75,000. 

Last year, at Boyes Turner, we were delighted to report our mesothelioma team’s success in securing a settlement for a client which included the cost of this treatment as a separate aspect of his claim. We insisted that as our medical expert believed our client should receive this treatment, he should not have to use the compensation he was awarded for other areas of his loss if he needed the immunotherapy treatment in the future. 

Fortunately, our client did not have to go through court proceedings to achieve his settlement, but we were delighted to hear that in a recent mesothelioma claim, the court has now ordered that treatment for immunotherapy should be funded by the defendant’s insurers.

Instead of waiting for the treating doctors to advise that the mesothelioma sufferer could have immunotherapy treatment, the court in an attempt to reach a quick settlement for the injured claimant, ordered that he could at any time request the costs of his immunotherapy treatment be funded by the insurers.

An order was given for periodical payments, so that mesothelioma claims can be settled without the injured claimant having to wait until their condition deteriorates to the point that their need for immunotherapy treatment is confirmed. The claimant can have the peace of mind of knowing that if or when they need immunotherapy treatment, the insurers have agreed to fund it automatically, whatever the cost.

At Boyes Turner we work hard to ensure that as many of our mesothelioma-affected clients as possible receive lifetime settlements, and we welcome the good news that we do not have to delay the outcome of any mesothelioma claims pending the decision on eligibility for immunotherapy treatment.

Having successfully recovered the cost of immunotherapy treatment for our own eligible mesothelioma-affected clients, we will continue to push the boundaries to improve compensation in mesothelioma claims.

Mesothelioma trials

Our asbestos team are committed to helping change the futures of mesothelioma patients by continuing to research the disease and striving to improve management of symptoms.

Charities such as Mesothelioma UK are strong advocates of ongoing trials and improvements on symptom management for mesothelioma patients and the Boyes Turner asbestos claims team support their efforts with annual sponsorship and fundraising.  

With a number of different trials now available for mesothelioma patients, this decision gives hope that settlement can still be reached in mesothelioma claims without eliminating the opportunity for a client to recoup their costs of any future experimental treatment.

If you or a family member has been diagnosed with mesothelioma or any other asbestos related disease, we may be able to help. Contact us on 0800 884 0718 or email IDClaims@boyesturner.com for a free initial discussion.

Positive result for mesothelioma claimants in Bussey v Anglia Heating Ltd

We are delighted to read that the Bussey’s appeal has been allowed and that the Judges rejected Technical Data Note 13 as the test in determining the applicable levels of asbestos exposure in mesothelioma cases. 

David Bussey was a plumber. He was exposed to asbestos during two periods of employment so there was more than one defendant to the claim. The claim against Avery Way Electronics Limited settled for £150,000 and the case continued against the remaining defendant, Anglia Heating Limited, with whom he was employed from about 1965 to 1968. During that time he handled and cut asbestos cement pipes (with a hacksaw), swept up asbestos and used asbestos rope for caulking joints. 

When the case first came to trial, the judge ruled that his asbestos exposure fell below the levels set out in Technical Data Note 13 (TDN13). TDN13 was a document issued by HM Factory Inspectorate in March 1970. This stated that criminal liability would not be incurred where the concentration of asbestos dust in the workplace was kept below certain specified limits.

In the case of Williams –v- University of Birmingham [2001] EWCA CIV 12 42, it was held that a claim could not succeed if the exposure was below the levels in TDN13. This made it far more difficult to succeed in obtaining justice for injured victims in low level asbestos mesothelioma cases. The judge in Williams laid down a binding proposition that employers were entitled to regard exposure at levels below those identified in TDN13 as safe, resulting in TDN13 being used as a guide as to what were acceptable and unacceptable levels of exposure in 1974. 

However, the Court of Appeal judgment in Bussey rejects the proposition that employers were entitled to regard exposure levels below those specified in TDN13 as being safe. Lord Justice Jackson says in the judgment that: “TDN13 sets out the exposure levels which, after May 1970, would trigger a prosecution by the Factory Inspectorate. That is a relevant consideration. It is not determinative of every case”. 

The decision in Bussey means that while TDN13 is a guide, it is not the benchmark for asbestos exposure and TDN13 does not establish a safe limit for exposure to asbestos. 

We are delighted that the often-quoted benchmark of TDN13 has now been overturned. 

The case has been sent back to the trial judge for him to re-determine the issue of liability and we are now awaiting that decision.

If you or a family member has been diagnosed with mesothelioma or any other asbestos related disease, we may be able to help. Contact us on 0800 884 0718 or email IDClaims@boyesturner.com for a free initial discussion.

Education Bursary - Alison Bain's story

As specialists in mesothelioma and other asbestos-related disease claims, Boyes Turner appreciate the valuable work carried out by the lung cancer nurses who support and care for victims of asbestos exposure during their hospital treatment and palliative care. 

In recognition of the value of their work, the importance of ongoing education and research into asbestos disease and the significant costs involved in updating their knowledge and skills, Boyes Turner offer sponsorship to nurses involved in thoracic oncology via an educational bursary. The bursary is awarded selectively, on application, to a limited number of nurses each year at Boyes Turner’s discretion.

Alison Bain, Lead Clinic Nurse Specialist at Royal Stoke University Hospital, reviews her experience after receiving sponsorship to attend the 2017 Annual Conference of the National Lung Cancer Forum for Nurses (NLCFN).

“The National Lung Cancer Forum for Nurses Annual Conference provides a tremendous opportunity for pollination of new ideas, innovations, learning from past experiences and is an invaluable resource to all that attend.

This year’s conference was fantastic, so I am truly grateful to Boyes Turner LLP for providing funding; without this, I certainly would not have been able to go.

The programme delivered an excellent range of patient centred topics, covering interesting facts, strategic development and interventions. On a personal level, conference highlights included the interactive sessions, debate and Symposium sessions.

Drew Povey was an exceptional motivational speaker; his delivery on leadership and ‘Making THE Difference’ was fantastic and an inspiration to all of us. This was a session not to be missed and something that will be etched on the minds of members for many years to come!

The interactive session on tobacco addiction, with our role, as frontline CNSs, playing a key role in tackling this problem, was entertaining to say the least and stimulated competition within the groups. Likewise, the debate for the right to a HNA was extremely witty, well delivered but also challenged personal opinions and provided an opportunity for reflection.

Consideration for future workforce planning and establishing competencies required for the next generation of Nurse Specialist, debate around the necessity to adapt to the ever-changing environment and push for succession planning strategies as budgets tighten, stimulated many discussions about CNS personal and academic development. Group work created an initial draft of bullet points which were considered to be essential in the validation of lung cancer specific competencies. Other broader issues gave ‘food for thought’ on sustainable and viable working practices, the need to adapt and be creative and how to implement an accelerated diagnostic pathway.

New developments, research and treatment considerations for mesothelioma and NSCLC third generation agents, poster presentations and the general presence of sponsored stands ensured that the event catered for all needs.

A truly enjoyable event, thank you.”

Alison Bain, Lead Clinic Nurse Specialist, Royal Stoke University Hospital

To learn more about our Education Bursary and how you can get involved please contact bursaries@boyesturner.com.

 

Compensation award for former telecommunications engineer from Diffuse Mesothelioma Payment Scheme

Boyes Turner’s specialist industrial disease team were instructed by Joseph* following his diagnosis of mesothelioma, an asbestos related cancer.

Joseph had been exposed to asbestos dust while working for Sterdy Telephones, a telecommunications company in London in the late 1960s and early 1970s. He had joined Sterdy Telephones straight from school as an apprentice in telecommunications engineering. 

He worked in telephone exchanges where he was required to lay cables, many of which had asbestos insulation to protect them. He had to trim, strip and cut the cables to size.  When he cut into the insulation, this created dust which went on his hands and his clothes.

He had to drill holes into insulation panels, known as ‘Transite covers’, in order to install the wiring. These contained asbestos and, when Joseph drilled into them, dust would circulate. When he dragged the cables through the holes, this further disturbed the panels and created more dust.    

He also moved fire breakers, which were cloth bags filled with asbestos. He dragged them into place, which caused dust to fall out of the bags.  This would gather on the floor and be trodden in throughout the day, causing it to circulate further.  

We investigated Sterdy Telephones and discovered that they were dissolved many years ago.  We were unable to trace any employers’ liability insurance from Joseph’s time of employment. This is a common problem in asbestos cases because employers’ liability insurance was not mandatory until 1972. Even where a policy was in place at the time of our client’s employment, it can be hard to trace decades later, as there was no central database of insurance policies at this time. 

As there was no traceable insurer, we made an application under the Diffuse Mesothelioma Payment Scheme, which was set up to compensate victims of mesothelioma who were negligently exposed to asbestos by uninsured employers. 

We took a detailed statement from Joseph which described his asbestos exposure at Sterdy Telephones, and we assisted him in completing the application form. The application was initially unsuccessful, as the administrators of the scheme felt that there was not enough evidence that our client was negligently exposed to asbestos. In order to satisfy the administrators’ concerns we traced a former Boyes Turner client who had also worked in telephone exchanges in the 1960s and 1970s and obtained his permission to use his statement from his former claim to help our client with his application. We took a further supplementary statement from Joseph setting out in detail how he was exposed to asbestos at Sterdy Telephones and obtained an opinion from an expert engineer, which supported the assertion that Joseph would have been negligently exposed to asbestos when working for Sterdy Telephones. Then we submitted a request for the administrators of the scheme to review their decision. They did so, overturning the previous decision, and awarded Joseph £179,091 gross compensation.

While no amount of money can make up for what Joseph and his family are going through, we were pleased that we were able to assist him at such a difficult time.

If you or a family member has been diagnosed with mesothelioma or any other asbestos related disease, we may be able to help.  Contact us on 0800 884 0718 or email IDClaims@boyesturner.com for a free initial discussion

*Client name changed for anonymity

Should cohabitees receive bereavement damages

This was a question recently faced by the Court of Appeal after Ms Jakki Smith took the Secretary of State for Justice to Court for breaching her human rights.

Who can claim bereavement damages?

The Fatal Accidents Act 1976 gives rise to the right to claim bereavement damages. The Act allows the wife, husband or civil partner of the deceased to claim damages for their bereavement. Payment is also made to the parents of the deceased where the deceased was a minor. The current payment for bereavement damages is £12,980. At the time that Ms Smith’s partner, John Bulloch, died it was £11,800 and this was the amount she was seeking.

Does a cohabitee get anything?

Unlike the payment for bereavement damages, which a cohabitee is not entitled to claim under the Act, a cohabitee can claim for a financial dependency on the deceased. This claim is possible where the deceased and his partner have been cohabiting for at least 2 years before the death and have been cohabiting as husband and wife.

What was Ms Smith’s case?

Ms Smith argued that by excluding her from those people entitled to claim bereavement damages the Government was breaching her Human Rights. The Court of Appeal agreed with Ms Smith and found that section 1A of the Fatal Accidents Act 1976 was incompatible with Article 14 in conjunction with Article 8 of the European Convention on Human Rights.

Unfortunately, although Ms Smith’s case will set a precedent for other unmarried cohabiting partners to seek bereavement damages, she will not benefit from the decision. This is because although the Secretary of State was acting in a way which was incompatible with Ms Smith’s convention rights, they could not have acted differently due to the provision of the Fatal Accidents Act which does not allow cohabitees to claim bereavement damages.  

How does this affect mesothelioma and asbestos claims?

In giving his judgment Sir Terence Etherton MR commented on the declining “popularity of the institution of marriage and the increase in the number of cohabiting couples”. According to the Office of National Statistics in a report on “Families and Households” in 2015, “cohabiting couples continues to be the fastest growing family type in the UK, reaching 3.2 million cohabiting families”.

This decision can be used as a precedent to persuade defendants that bereavement damages should be paid to cohabitees in line with financial dependency claims under the Fatal Accidents Act 1976. 

Bereavement damages frequently form a part of mesothelioma and asbestos claims and therefore this is a decision which will benefit a number of our clients. However, the Fatal Accidents Act 1976 has not yet changed to allow a statutory entitlement to bereavement damages for cohabitees and we look forward to seeing a change to the Fatal Accidents Act 1976 in the near future.
 

  • Page 1 of 10

The service was personal, professional and considered. I was treated so kindly and in the end I knew that not only had I found the right organisation but also the right person.

Boyes Turner client

Get in touch

Please get in touch 0800 029 4802

Or we are happy to call you back at a time that suits you

Office open Mon - Fri: 08:30 - 18:00